PMI Picard Medical, Inc.
Fundamentals / CIK 0002030617 / USDPicard Medical, Inc. reported $5.33M in revenue and a net loss of $19.79M for the trailing twelve months ended September 30, 2026 (down 81.7% year over year), with a 26.2% gross margin and a -267.2% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PMI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$5.33M -81.7% YoY
-
Operating Income TTM-$14.24M -267.2% margin
-
Net Income TTM-$19.79M -371.2% net margin
-
Diluted EPS TTM-- Split-adjusted
-
Free Cash Flow TTM-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$67K Total debt: $188K
Annual revenue and net income
2 fiscal years (2024 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 |
|---|---|---|
| Revenue | $4.94M | $4.39M |
| Cost of Revenue | $5.14M | $4.50M |
| Gross Profit | -$204K | -$112K |
| Research & Development | $3.05M | $3.38M |
| Selling, General & Admin | $10.00M | $10.22M |
| Total Operating Expenses | $13.05M | $13.60M |
| Operating Income | -$13.26M | -$13.71M |
| EBITDA | -$13.09M | -$13.49M |
| Income Before Tax | -$26.97M | -$21.07M |
| Income Tax Expense | $35K | -$15K |
| Net Income | -$27.00M | -$21.05M |
| Basic EPS | -$37.50 | -$149.50 |
| Basic Shares Outstanding | 724.7K | 158.9K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $217K | $2.95M | $1.15M | $1.01M | $1.19M | $2.13M | $620K | -- |
| Cost of Revenue | $122K | $2.34M | $875K | $598K | $1.32M | $2.26M | $978K | -- |
| Gross Profit | $95K | $616K | $275K | $411K | -$130K | -$127K | -$358K | -- |
| Research & Development | $321K | $1.37M | $1.90M | $547K | $951K | $743K | $808K | -- |
| Selling, General & Admin | $1.88M | $3.87M | $2.89M | $2.87M | $2.41M | $2.65M | $2.08M | -- |
| Total Operating Expenses | $2.20M | $5.25M | $4.79M | $3.41M | $3.36M | $3.39M | $2.89M | -- |
| Operating Income | -$2.10M | -$4.63M | -$4.51M | -$3.00M | -$3.49M | -$3.52M | -$3.25M | -- |
| EBITDA | -$2.06M | -$4.58M | -$4.46M | -$2.96M | -$3.45M | -$3.48M | -$3.20M | -- |
| Interest Expense | -- | -- | -- | -- | -- | $2.43M | -- | -- |
| Income Before Tax | -$2.22M | -$5.65M | -$7.62M | -$4.29M | -$10.43M | -$6.72M | -$5.53M | -- |
| Income Tax Expense | $0 | $7.0K | $0 | $4.0K | $0 | $0 | $31K | -- |
| Net Income | -$2.22M | -$5.66M | -$7.62M | -$4.29M | -$10.43M | -$6.72M | -$5.56M | -$8.84M |
| Basic EPS | -$0.95 | -$152.50 | -$5.00 | -- | -$9.57 | -$2,119.50 | -$40.00 | -- |
| Basic Shares Outstanding | 2.3M | 37.1K | 1.5M | -- | 1.1M | 3.5K | 159.3K | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 |
|---|---|---|
| Cash & Cash Equivalents | $7.45M | $96K |
| Cash & Short-Term Investments | $7.45M | $96K |
| Accounts Receivable, Net | -- | $513K |
| Inventory | $7.30M | $8.12M |
| Total Current Assets | $20.73M | $9.79M |
| Property, Plant & Equipment, Net | $183K | $227K |
| Goodwill | $615K | $615K |
| Intangible Assets | $509K | $596K |
| Total Non-Current Assets | $1.82M | $2.31M |
| Total Assets | $22.55M | $12.11M |
| Accounts Payable | $2.08M | $5.29M |
| Other Current Liabilities | $499K | $493K |
| Total Current Liabilities | $18.70M | $35.33M |
| Total Non-Current Liabilities | $64K | $517K |
| Total Liabilities | $18.76M | $35.84M |
| Total Debt (incl. Leases) | $527K | $434K |
| Common Stock | $0 | $1.0K |
| Retained Earnings | -$76.84M | -$49.84M |
| Accumulated Other Comp. Income | $228K | $278K |
| Total Stockholders' Equity | $3.79M | -$44.00M |
| Total Equity | $3.79M | -$44.00M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $67K | $38K | $121K | $7.45M | $2.81M | $410K | $96K |
| Cash & Short-Term Investments | $67K | $38K | $121K | $7.45M | $2.81M | $410K | $96K |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | $1.30M | $513K |
| Inventory | $6.38M | $5.97M | $7.45M | $7.30M | $6.55M | $7.00M | $8.12M |
| Total Current Assets | $7.63M | $7.59M | $9.51M | $20.73M | $11.59M | $9.64M | $9.79M |
| Property, Plant & Equipment, Net | $140K | $162K | $184K | $183K | $169K | $188K | $227K |
| Goodwill | $615K | $615K | $615K | $615K | $615K | $615K | $615K |
| Intangible Assets | $443K | $465K | $487K | $509K | $531K | $553K | $596K |
| Total Non-Current Assets | $1.44M | $1.57M | $1.71M | $1.82M | $1.93M | $2.06M | $2.31M |
| Total Assets | $9.06M | $9.17M | $11.22M | $22.55M | $13.52M | $11.70M | $12.11M |
| Accounts Payable | $3.50M | $3.32M | $2.71M | $2.08M | $3.12M | $6.37M | $5.29M |
| Other Current Liabilities | $515K | $515K | $499K | $499K | $6.0K | $505K | $493K |
| Total Current Liabilities | $7.73M | $7.45M | $12.66M | $18.70M | $5.37M | $45.64M | $35.33M |
| Total Non-Current Liabilities | $0 | $0 | $9.0K | $64K | $180K | $295K | $517K |
| Total Liabilities | $7.73M | $7.45M | $12.67M | $18.76M | $5.55M | $45.93M | $35.84M |
| Total Debt (incl. Leases) | $188K | $311K | $417K | $527K | $616K | $429K | $434K |
| Common Stock | $0 | $0 | $8.0K | $0 | $7.0K | $1.0K | $1.0K |
| Retained Earnings | -$92.34M | -$90.12M | -$84.46M | -$76.84M | -$72.55M | -$62.13M | -$49.84M |
| Accumulated Other Comp. Income | $262K | $269K | $246K | $228K | $230K | $262K | $278K |
| Total Stockholders' Equity | $1.33M | $1.72M | -$1.45M | $3.79M | $7.97M | -$54.49M | -$44.00M |
| Total Equity | $1.33M | $1.72M | -$1.45M | $3.79M | $7.97M | -$54.49M | -$44.00M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 |
|---|---|---|
| Net Income | -$27.00M | -$21.05M |
| Depreciation & Amortization | $163K | $226K |
| Stock-Based Compensation | $754K | $886K |
| Change in Receivables | -$120K | $116K |
| Change in Inventory | $390K | -$1.33M |
| Change in Payables | -$3.21M | $2.21M |
| Operating Cash Flow | -$15.67M | -$11.87M |
| Investing Cash Flow | -- | $0 |
| Common Stock Issued | $15.21M | $0 |
| Financing Cash Flow | $27.08M | $11.74M |
| Net Change in Cash | $11.36M | -$148K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$2.22M | -$5.66M | -$7.62M | -$4.29M | -$10.43M | -$6.72M | -$5.56M | -$8.84M |
| Depreciation & Amortization | $44K | $45K | $46K | $40K | $41K | $40K | $42K | -- |
| Stock-Based Compensation | $93K | $1.38M | $165K | $226K | $204K | $183K | $141K | -- |
| Change in Receivables | $470K | -$18K | $27K | $259K | $408K | -$1.29M | $506K | -- |
| Change in Inventory | -$483K | $1.05M | -$321K | -$531K | $266K | $901K | -$246K | -- |
| Change in Payables | $176K | $612K | $632K | -$1.04M | -$3.25M | $850K | $227K | -- |
| Operating Cash Flow | -$2.00M | -$1.35M | -$3.80M | -$4.38M | -$6.51M | -$2.54M | -$2.24M | -- |
| Capital Expenditure | $0 | $0 | -$26K | -- | $0 | $0 | $0 | -- |
| Free Cash Flow | -$2.00M | -$1.35M | -$3.83M | -- | -$6.51M | -$2.54M | -$2.24M | -- |
| Investing Cash Flow | $0 | $0 | -$26K | -- | $0 | $0 | $0 | -- |
| Common Stock Issued | $0 | $0 | $0 | $0 | $13.72M | $985K | $500K | -- |
| Financing Cash Flow | $2.03M | $1.25M | -$7.52M | $13.02M | $8.95M | $2.28M | $2.83M | -- |
| Net Change in Cash | $29K | -$83K | -$11.33M | $8.64M | $2.40M | -$278K | $592K | -- |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 |
|---|---|---|
| Gross Margin | -4.1% | -2.6% |
| Operating Margin | -268.4% | -312.3% |
| Net Profit Margin | -546.6% | -479.5% |
| Return on Equity (ROE) | -712.6% | -- |
| Return on Assets (ROA) | -119.8% | -173.9% |
| Current Ratio | 1.11x | 0.28x |
| Quick Ratio | 0.72x | 0.05x |
| Debt to Equity | 0.14x | -- |
| Revenue Growth (YoY) | +12.5% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 26.2% | 18.6% | 7.8% | -4.1% | -- | -- | -- | -- |
| Operating Margin | -267.2% | -248.1% | -265.1% | -268.0% | -- | -- | -- | -- |
| Net Profit Margin | -371.2% | -444.3% | -530.5% | -545.8% | -- | -- | -- | -- |
| Return on Equity (ROE) | -1487.7% | -1631.3% | -- | -712.6% | -395.9% | -- | -- | -- |
| Return on Assets (ROA) | -218.3% | -305.4% | -259.0% | -119.8% | -233.3% | -233.5% | -- | -173.9% |
| Current Ratio | 0.99x | 1.02x | 0.75x | 1.11x | 2.16x | 0.21x | -- | 0.28x |
| Quick Ratio | 0.16x | 0.22x | 0.16x | 0.72x | 0.94x | 0.06x | -- | 0.05x |
| Debt to Equity | 0.14x | 0.18x | -- | 0.14x | 0.08x | -- | -- | -- |
| Revenue Growth (YoY) | -81.7% | +38.6% | +85.5% | -- | +34.7% | +207.1% | -- | -- |